Competitor Analysis
An effetive venous access sheath must have moderate to high kink resistance, moderate to high bendin stiffness, moderate flexibility, as well as low insertion and guiding forces. All these factors lead to reduced complications and access site bleeding. Our competitor analysis below indicates that our product leads in these categories.
Market Strategy
Developed in association with Edwards Lifesciences, our product is slated for internal development and release rather than entreprenureal launch. Therefore, our market strategy is highly dependent on factors internal to Edwards Lifesciences, rather than those factors which determine entreprenureal success for typical startup companies.
This is promising for our future success, as Edwards Lifesciences already has a considerable stake in the growing transcatheter heart valve industry, with Sapien III artificial heart valves and Evoque delivery systems already launched.
